Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
11:07:08 2026-08-12 am EDT
|
5-day change | 1st Jan Change | ||
| 57.70 EUR | -1.11% |
|
-1.53% | -9.06% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.98B 3.44B 2.79B 2.55B 4.8B 328B 4.88B 32.76B 12.83B 164B 12.93B 12.65B 548B | P/E 2026 * |
20.9x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.97B 3.42B 2.78B 2.54B 4.77B 327B 4.85B 32.58B 12.76B 164B 12.86B 12.58B 545B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 3.26x |
| Free-Float |
31.63% | Yield 2026 * |
1.65% | Yield 2027 * | 2% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| Jul. 23 | Spanish stocks - Factors to watch on July 23 | RE |
| Feb. 25 | Spanish stocks - Factors to watch on Feb 25 | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 25-03-05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | -1.11% | ||
| 1 week | -1.53% | ||
| Current month | -1.37% | ||
| 1 month | +6.26% | ||
| 3 months | -5.48% | ||
| 6 months | -25.44% | ||
| Current year | -9.06% |
| 1 week | 57.55 |  | 59.25 |
| 1 month | 53.1 | | 60.25 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 4/13/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 3/15/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.11% | -1.53% | +6.75% | +21.48% | 3.44B | |
| +0.20% | +4.02% | +90.30% | +126.18% | 1,083B | |
| +0.14% | +0.91% | +50.44% | +49.86% | 626B | |
| -0.13% | +1.43% | +25.72% | +64.00% | 442B | |
| -1.34% | -0.22% | +47.69% | +37.40% | 363B | |
| -1.58% | -0.32% | +28.92% | +36.45% | 295B | |
| -1.36% | -2.81% | +5.52% | +5.25% | 248B | |
| +0.37% | +1.82% | +45.72% | +59.13% | 224B | |
| -2.51% | +1.53% | -6.77% | -51.75% | 210B | |
| +0.49% | +3.51% | +13.64% | +70.80% | 168B | |
| Average | -0.65% | +2.49% | +30.79% | +41.88% | 366.26B | |
| Weighted average by Cap. | -0.34% | +4.28% | +48.90% | +64.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 890M 722M 659M 1.24B 84.93B 1.26B 8.47B 3.32B 42.51B 3.34B 3.27B 142B | 891M 1.03B 834M 761M 1.43B 98.04B 1.46B 9.78B 3.83B 49.07B 3.86B 3.78B 164B |
| Net income | 129M 148M 120M 110M 207M 14.15B 210M 1.41B 553M 7.08B 557M 545M 23.62B | 174M 201M 163M 149M 280M 19.14B 284M 1.91B 748M 9.58B 753M 737M 31.96B |
| Net Debt | -16.21M -18.71M -15.18M -13.85M -26.06M -1.78B -26.5M -178M -69.73M -893M -70.25M -68.72M -2.98B | -81.51M -94.05M -76.3M -69.62M -131M -8.97B -133M -895M -351M -4.49B -353M -345M -14.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | €57.75 | -1.03% | 49,688 |
| 26-08-11 | €58.35 | -0.60% | 64,274 |
| 26-08-10 | €58.70 | +0.60% | 75,610 |
| 26-08-07 | €58.35 | -0.43% | 66,635 |
| 26-08-06 | €58.60 | -0.09% | 99,390 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
